Isochrysis Galbana Extract.

This microalgal oil is rich in docosahexaenoic acid, which oxidises quickly once extracted from the cell. Tocopherol is the standard chain-breaking antioxidant that keeps the fatty acid intact through storage and digestion.

Isochrysis is grown commercially for its docosahexaenoic acid content, so the extract adds to the same DHA intake as a declared DHA dose rather than acting separately.

The alga supplies DHA with only small amounts of eicosapentaenoic acid, and conversion back from DHA to EPA in humans is limited. Pairing with an EPA source rounds out the omega-3 profile.

Astaxanthin sits across the membrane bilayer and quenches radicals in the same lipid compartment where long-chain omega-3s are most prone to peroxidation. It is a common companion in algal oil formulations.

Haptophyte microalgae of this group carry fucoxanthin as a main accessory pigment, so the extract already contributes to a fucoxanthin intake. Adding purified fucoxanthin stacks the same carotenoid.

Sustained long-chain omega-3 intake shifts platelet eicosanoid balance and modestly lengthens normal clotting time, and nattokinase acts on fibrin by a separate route. The two effects add together.

Fucoxanthin and the algal carotenoids are lipophilic and need a lipid phase and bile-driven micelle formation to cross the intestinal wall. A medium-chain triglyceride carrier provides that phase inside the capsule itself rather than relying on the meal. This is formulation and absorption chemistry, not a tested combination.

Phospholipid emulsifiers reduce the droplet size of an algal oil dispersion, which increases the surface available for lipase and speeds micelle formation. Emulsified carotenoid preparations show higher plasma appearance than coarse oils in absorption studies. Plasma appearance is an absorption marker and not a health outcome.

Rosemary extract standardised on carnosic acid is a common oil-phase antioxidant that slows peroxidation of long-chain polyunsaturated fatty acids during shelf life. Algal DHA oils are among the most oxidation-prone lipids in the category. The role here is protecting the ingredient in the bottle rather than any effect in the body.

Mixed tocopherols terminate the lipid radical chain reaction inside the oil phase and are a standard antioxidant system for polyunsaturated oils. The blend carries alpha, gamma and delta tocopherols, which differ in how they behave in an oil phase versus in tissue, so oil stabilisers are specified as a blend rather than on alpha alone. The stored partner list already holds vitamin E as a nutrient; this row is about the mixed-tocopherol blend used in the oil.

Ascorbate regenerates the tocopheroxyl radical back to tocopherol at the lipid-water interface, so the water-soluble and fat-soluble antioxidants work as a couple rather than in isolation. In an emulsified algal oil that interface is where oxidation starts. The recycling reaction is settled chemistry.

Carotenoids share micellar incorporation and the same intestinal transporters, so a large dose of one xanthophyll reduces the uptake of another taken in the same meal. Fucoxanthin and lutein are both xanthophylls and compete on that route. Absorption studies measure plasma concentrations, which are uptake markers.

Zeaxanthin uses the same micellar and transporter route as other xanthophylls, so co-dosing at high levels splits a shared absorption capacity. Formulators separate large carotenoid doses across meals for this reason. What is measured in this literature is plasma appearance, not a downstream effect.

High-dose beta-carotene lowers the plasma appearance of co-ingested xanthophylls in absorption studies, a well-documented competition among carotenoids. An algal extract carrying fucoxanthin sits on the same route. This is a competition worth flagging on a label rather than a reason to avoid either.

Lycopene is a hydrocarbon carotenoid that partitions into the same micelles as fucoxanthin, so the two draw on one absorption capacity when taken together. The competition is dose-dependent and modest at ordinary supplement levels. Reported endpoints are plasma concentrations.

Krill oil delivers EPA and DHA largely bound to phospholipids, while an Isochrysis extract delivers DHA in algal triglycerides and glycolipids. Both raise the same long-chain omega-3 pool by different carriers, so their label amounts overlap rather than stack. Anyone counting total DHA should add the two.

Catechins and fucoxanthin both quench reactive species in laboratory assays, and formulators pair them in metabolic products for that reason. Assay antioxidant capacity is a chemical measurement in a tube and does not carry to an effect in a person. Concentrated green tea extracts also come with their own intake considerations at higher doses.

Ubiquinone is highly lipophilic and is routinely dissolved in an oil carrier for absorption, so an algal oil can serve as that carrier while contributing its own fatty acids and carotenoids. Co-formulation is a solubility argument. It does not imply the two act on the same target.

Dietary DHA is esterified into phospholipids, and phosphatidylcholine supplies the head group those molecules are built around. Supplying both an omega-3 source and a choline-bearing phospholipid touches two halves of the same membrane molecule. Membrane fatty acid composition is a compositional marker.

Marine biomass concentrates iodine from seawater to widely varying degrees, and microalgal powders carry far less than kelp but not always zero. Anyone already taking a separate iodine source has reason to look at the certificate of analysis rather than assume the algal contribution is nil. The relevant number is per-lot and belongs to the supplier's analysis, not to a general claim.